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Abstract
Background: Cow milk is a natural source of the cis 9, trans 11 isomer of conjugated linoleic acid
(c9,t11-CLA) and trans vaccenic acid (VA). These fatty acids may be considered as functional foods,
and the concentration in milk can be increased by e.g. sunflower oil supplementation to the dairy
cow feed.
The objective of this study was to compare the effects of regular butter with a special butter
naturally enriched in c9,t11-CLA and VA on plasma lipids in female growing pigs. The experimental
period lasted for three weeks and the two diets provided daily either 5.0 g c9,t11-CLA plus 15.1 g
VA or 1.3 g c9,t11-CLA plus 3.6 g VA.
Results: The serum concentrations of c9,t11-CLA, VA and alpha-linolenic acid were increased and
myristic (14:0) and palmitic acid (16:0) were reduced in the pigs fed the CLA+VA-rich butter-diet
compared to regular butter, but no differences in plasma concentrations of triacylglycerol,
cholesterol, HDL-cholesterol, LDL-cholesterol, LDL particle size distribution or total cholesterol/
HDL cholesterol were observed among the two dietary treatment groups.
Conclusion: Growing pigs fed diets containing butter naturally enriched in about 20 g c9,t11-CLA
plus VA daily for three weeks, had increased serum concentrations of alpha-linolenic acid and
decreased myristic and palmitic acid compared to pigs fed regular butter, implying a potential
benefit of the CLA+VA butter on serum fatty acid composition. Butter enriched in CLA+VA does
not appear to have significant effect on the plasma lipoprotein profile in pigs.
Background
Milk and dairy products have long traditions in human
nutrition, but for some decades milk fat has been associ-
ated with negative health effects. However, the association
between milk fat and plasma lipids is ambiguous, and a
paradox. Several studies show no convincing evidence
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that dairy products increase the risk of cardiovascular dis-
ease and that milk is harmful [1-4]. Some studies indicate
that a moderate intake of milk fat may reduce the risk of
cardiac diseases, possibly through reduced formation of
small dense low density lipoprotein particles (sdLDL) [5].
The sdLDL are thought to undergo oxidation more read-
ily, or to be harder bound to the arterial endothelia sur-
face [6]. Dairy milk fat contains numerous fatty acids that
might affect formation of sdLDL, such as saturated fatty
acids, c9,t11-CLA isomer and VA [7,8]. Evidence for
hypolipidemic properties of c9,t11-CLA has been given,
and administration of CLA has been shown to modulate
plasma lipid concentration in both human and animal
models, and to reduce markers associated with athero-
genic risk [8-10]. These findings have led to considerable
interest in methods for naturally increasing the c9,t11-
CLA content in milk, and milk products that are naturally
enriched in CLA has been advocated. CLA is a group of
polyunsaturated fatty acids found naturally in beef, lamb
and dairy products, and c9,t11-CLA is the main form of
CLA (18:2 c9,t11). It can be produced in ruminants by
bacterial isomerisation of linoleic acid (18:2 c9,c12) in
the rumen. In ruminants and non-ruminants it can be
produced in most tissues by delta-9 desaturation of VA
(18:1 t11) [11,12]. The concentration of c9,t11-CLA and
VA in milk fat is highly dependent on the feed composi-
tion; VA is an intermediate product of biohydrogenation
of unsaturated fatty acids in the rumen, and feedstuff rich
in linoleic or α-linolenic acids enhance CLA and VA in
milk [13]. Since c9,t11-CLA in milk fat is associated with
VA, milk rich in c9,t11-CLA is also rich in VA, its precursor
[12]. In general, trans fatty acids are associated with
increased plasma cholesterol and risk for coronary heart
disease. Therefore the concentration of VA in milk has
been of concern. However, VA's effect on plasma choles-
terol has not been entirely understood since epidemiolog-
ical studies have shown that trans fatty acids from animal
sources did not increase risk for coronary artery disease
[14].
The objective of the study presented here was to compare
effects on plasma lipid- and fatty acid profile in growing
pigs that had been given diets containing regular butter
(REG) or butter naturally enriched in CLA plus VA.
Results and discussion
Feed intake and weight gain
In the present study, there were no significant differences
in the feed intake (in average 1.65 kg and 1.67 kg per day),
weight gain (17.9 kg and 18.4 kg) and final body weight
(61.2 kg and 61.9 kg) in the REG and CLA+VA treatment
groups, respectively (data not shown). The CLA isomer
involved in decreasing body fat is the t10,c12-CLA isomer,
but there are no concluding evidence of such effects of the
c9,t11-CLA isomer [15,16].
Fatty acid (FA) composition of diets
The CLA+VA rich butter diet differed from the regular but-
ter diet with a higher concentrations of c9,t11-CLA, VA,
oleic acid (18:1,9c), linoleic (18:2) and α-linolenic acid
(18:3), and less 10:0, 12:0, myristic acid and palmitic acid
(Table 1). This diet provided daily 5.0 g CLA and 15.1 g
VA, and the intake of these two fatty acids was about four
times higher in the CLA+VA dietary treatment compared
to the REG dietary treatment. Intake of CLA+VA as percent
of average body weight was about 0.04% in the CLA+VA
treatment group, and 0.01% in the REG group. Alpha-
linolenic acid was about 30% higher and palmitic and
myristic acid about 25% lower in the CLA+VA diet com-
pared to REG.
To provide a high intake of natural CLA and VA, the exper-
imental diets were rich in fat; 19% fat in both diets, giving
as much as 46% of the energy (E%) from fat. The pigs
liked the diets, and in accordance to others [17] pigs tol-
erated well a high fat diet.
Serum fatty acids
At the start of the experiment there were no differences
between the two experimental groups in the concentra-
tion of different FA in serum (data not shown). In con-
trast, at the end of the study it was significant differences
between the diet groups in concentration of several serum
FA (Table 2).
Table 1: Fatty acid composition of the diets, (g/100 g fatty acid 
methyl ester).
Fatty acid REGa CLA+VAb
10:0 2.43 1.61
12:0 2.88 2.13
14:0 10.32 8.02
14:1 0.93 0.79
16:0 28.09 20.84
16:1 1.65 1.13
18:0 11.09 10.75
18:1 t11 1.36 5.62
18:1 9c 22.03 25.11
18:2 n-6 7.09 9.21
18:3 n-3 1.13 1.51
c9,t11-CLA 0.53 1.85
20:4 n-6 0.07 0.09
20:5 n-3 0.07 0.10
22:5 n-3 0.07 0.07
22:6 n-3 0.02 0.05
Sumc 89.80 88.88
aDiet with regular butter as fat supplement
bDiet with CLA+VA rich butter as fat supplement
c Butter contains several unidentified fatty acids in small amounts 
(areal percent less than 0.5%).Lipids in Health and Disease 2008, 7:31 http://www.lipidworld.com/content/7/1/31
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The main FA in serum are palmitic acid, stearic acid, oleic
acid and linoleic acid, together accounting for about 70%
of total FA (Table 2). Pigs fed the CLA+VA diet had a 3.4
fold higher serum concentrations of c9,t11-CLA plus VA
compared to the REG diet group. Alpha-linolenic acid was
25% higher, and myristic and palmitic acid was 25% and
15% lower in the serum of CLA+VA compared to the REG
dietary treatment (Table 2). The mirroring effect of dietary
FA on serum FA is in accordance to several studies
[5,18,19]. The favourable increased serum concentrations
of the omega-3 fatty acid α-linolenic acid and the decrease
in the saturated palmitic and myristic acids may indicate
that the CLA+VA rich butter can have a positive role in the
western diet.
Plasma cholesterol, triacylglycerol and lipoproteins
At the start of the study, no differences between the groups
were observed for plasma concentrations of total choles-
terol, LDL-cholesterol, high density lipoprotein (HDL)-
cholesterol, sdLDL subclass particle diameter, the ratio
between total cholesterol and HDL cholesterol, free fatty
acids and triacylglycerol.
The dietary fatty acids in the CLA+VA treatment were
more favourable than in the REG diet; i.e. more oleic acid
(18:1c9), linoleic acid (18:2 n-6), and α-linolenic acid
(18:3 n-3), c9,t11-CLA and less myrisitc acid (14:0) and
palmitic acid (16:0) [20] (Table 1). In spite of intake of
the more favourable fatty acids in the CLA+VA treatment
group, the plasma concentration of recognized risk mark-
ers for atherosclerosis such as total cholesterol, LDL-cho-
lesterol, sdLDL, the ratio between total cholesterol and
HDL cholesterol and triacylglycerol did not decrease, and
HDL-cholesterol was not increased (Table 3). The lack of
response of CLA+VA enriched butter on lipoprotein pro-
files is in accordance to a human study [9]. It is also
shown no response on plasma lipoproteins in growing
pigs fed diets containing unsaturated plant fatty acids
compared to saturated animal fat [21]. In the present
experiment the two types of butter differed in several fatty
acids. Butter contains numerous fatty acids in minor
amounts that may have potential bioactive effects on lipid
metabolism. The CLA+VA butter contained a high con-
centration of VA. The intake of VA was considerable in the
CLA+VA group; 15.1 g per day compared to 3.6 g per day
in REG treatment group. Vaccenic acid is a substrate for
c9,t11-CLA in the animals own tissue, and in this way it is
desirable [11], but trans fatty acids in general has been
attributed to increased plasma cholesterol and also other
pathogenetic factors [20,22]. Given the high dosage of VA
supplied daily in the CLA+VA diet, it can not be excluded
that VA might have had opposite effects on plasma lipo-
proteins than CLA and other desirable fatty acids. It has
been reported by others that the natural combination of
CLA and VA had no detrimental effect on the blood lipid
profile in humans [9]. The fact that the high intake (about
20 g per day for pigs weighing in average about 50 kg) of
CLA+VA in combination improved serum fatty acid pro-
file and did not have an unfavorable effect of plasma lipo-
proteins can stimulate to new strategies to develop natural
CLA+VA rich dairy products.
Milk products have been shown to have an apparently
beneficial effect on LDL particle size distribution (giving
less of the sdLDL) [5]. From the Framingham Offspring
Study [23] it has been shown that subjects with a high
Table 2: Overall means in serum fatty acid concentration (g/100 
g fatty acid methyl ester)a
Fatty acid REGb CLA+VAc p
10:0 0.17 ± 0.05 0.12 ± 0.03 0.08
12:0 0.67 ± 0.44 0.54 ± 0.13 0.52
14:0 1.36 ± 0.31 1.03 ± 0.12 0.04*
14:1 0.32 ± 0.04 0.28 ± 0.05 0.18
16:0 20.1 ± 0.90 17.1 ± 0.75 <0.01*
16:1 1.02 ± 0.17 0.89 ± 0.13 0.16
18:0 16.3 ± 1.6 14.6 ± 0.9 0.054
18:1 9c 16.2 ± 1.7 16.2 ± 0.3 0.98
18:2 n-6 20.0 ± 1.3 21.6 ± 2.4 0.20
18:3 n-3 0.81 ± 0.13 1.02 ± 0.09 0.01*
18:1 t11 0.27 ± 0.05 1.09 ± 0.18 <0.01*
c9,t11-CLA 0.28 ± 0.08 0.80 ± 0.07 <0.01*
20:4 n-6 8.2 ± 1.0 8.1 ± 0.4 0.89
20:5 n-3 1.49 ± 0.19 1.46 ± 0.06 0.65
22:5 n-3 1.41 ± 0.15 1.47 ± 0.19 0.57
22:6 n-3 1.74 ± 0.34 1.46 ± 0.17 0.10
aValues given as mean ± SD, and p-values, n = 6.
bDiet containing regular butter as fat supplement
cDiet containing CLA+VA rich butter as fat supplement
* p < 0.05.
Table 3: Plasma lipids, lipoproteins and percent distribution of 
LDL-particles LDL-I, LDL-II, LDL-III and LDL-IVa
REGb CLA+VAc
Triglyceride 0.43 ± 0.07 0.46 ± 0.13
Total cholesterol mmol/l 3.61 ± 0.5 3.50 ± 0.4
HDL cholesterol mmol/l 1.44 ± 0.17 1.32 ± 0.21
LDL cholesterol (calculated) 1.98 ± 0.37 1.97 ± 0.33
Total cholesterol/HDL cholesterol 2.51 ± 0.15 2.65 ± 0.28
LDL cholesterol/HDL cholesterol 1.38 ± 0.15 1.49 ± 0.28
LDL peak size (Å) 243 ± 3.6 243 ± 3.2
Percent distributiond
LDL-I (%) 21.7 ± 7.1 25.0 ± 4.0
LDL-II (%) 47.5 ± 3.4 44.9 ± 1.9
LDL-III (%) 20.5 ± 4.2 18.5 ± 3.3
LDL-IV (%) 8.0 ± 1.8 9.2 ± 1.7
Nonesterified fatty acids mmol/l 0.48 ± 0.18 0.41 ± 0.09
aValues given as mean ± SD, n = 6.
bDiet containing regular butter as fat supplement
cDiet containing CLA+VA rich butter as fat supplement
d Represents the proportions of LDL-I, 27.0–25.0 nm; LDL-II, 25.0–
23.5 nm; LDL-III, 23.5–22.5 nm; LDL-IV, 22.5–21.0 nm.Lipids in Health and Disease 2008, 7:31 http://www.lipidworld.com/content/7/1/31
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intake of certain saturated fatty acids (4:0–10:0 and myr-
istic acid) abundantly found in milk products, have low-
ered levels of sdLDL. Other has shown that saturated fatty
acids (especially myristic- and palmitic acid) may affect
the distribution of the LDL particles, giving more of the
large LDLs [24]. The REG diet contained more 10:0,
myrisitic and palmitic acid, but no improvement in LDL
particle size was observed in the REG diet group.
Conclusion
A diet containing natural CLA+VA enriched butter
resulted in increased serum concentrations of CLA, vacce-
nic acid and α-linolenic acid, and reduced concentration
of myristic and palmitic acid in pigs compared to a diet
containing regular butter, indicating a potential health
benefit of the CLA+VA rich butter. However, no differ-
ences in plasma lipoproteins and LDL particle sizes were
observed among the two dietary treatment groups follow-
ing three weeks feeding. It is worth noting that a relatively
high intake of the trans fatty acid VA did not result in a
detrimental effect on the lipoprotein profile when it was
in combination with c9,t11-CLA. Perhaps is the combina-
tion of fatty acids in milk fat one reason to the milk fat
paradox?
Methods
Animal care
The experimental research on animals followed interna-
tionally recognized guidelines. All animals were cared for
according to laws and regulations controlling experiments
with live animals in Norway (The Animal Protection Act
of December 20th, 1974, and the Animal Protection Ordi-
nance Concerning Experiments with Animals of January
15th, 1996); according to the rules given by Norwegian
Animal Research Authority.
Animals and diets
Twelve growing female pigs (initial weight were 43.4 ± 1.5
kg) of a commercial Norwegian crossbreed ((Landrace ×
Yorkshire) × (Landrace × Duroc)) were selected for the
study. The pigs were reared indoors, and fed two times per
day in accordance to NRC requirements for nutrients for
growing pigs [25]. A veterinarian examined the pigs every
week.
Feed ingredients and fatty acid composition of the two
experimental diets are shown in Table 1 and 4, respec-
tively. The dietary treatment (diets produced at Borgen
Aktiemolle, Andebu, Norway) was identical except for fat
source; regular butter (Tine butter, Oslo, Norway) or
CLA+VA rich butter (Table 4). The CLA+VA butter was
specially produced for this experiment from milk from
dairy cows that were receiving a cereal based commercial
feed concentrate (8 kg per day), grass dominated pasture
with white clover and supplemented with sunflower oil
(500 ml per day, containing 60% 18:2, Karlshamn AB,
Karlshamn, Sweden). The CLA+VA rich butter contained
2.1 g c9,t11-CLA and and 6.3 g VA per 100 g fat. The reg-
ular butter contained 0.6 g c9,t11-CLA and 1.5 g VA per
100 g fat. The average daily intake of c9,t11-CLA and VA
in the CLA+VA treatment group was 5.0 g c9,t11-CLA,
15.1 g VA and in the REG group: 1.3 g c9,t11-CLA, 3.6 g
VA.
Study designs
The experimental period lasted for three weeks. Twelve
pigs were randomized into two groups (n = 6) and indi-
vidually fed one of two diets; CLA+VA or REG. The pigs
were weighed once every week and amount of feed was
adjusted according to body weight. At feeding time, pigs
were restrained in an individual feeding stall for about 1/
2 h, and feed intake was recorded.
Blood samples were obtained by vena cava puncture at the
start and at the end of the experiment. Blood samples were
taken after an overnight fasting in Na-heparin-, EDTA-
and empty vacuum tubes. Blood samples were immedi-
ately chilled on ice. Plasma and serum were obtained by
low speed centrifugation for 20 min at 1700 g. Plasma,
serum and whole blood (heparin blood) were frozen and
kept at -80°C until analyzed.
Table 4: Composition of experimental diets, (g per 100 g dry 
feed).
REGa CLA+VAb
Ingredients
Regular butter-fat 16.16 -
CLA rich butter-fat - 16.16
Oat 6.04 6.04
Wheat bran 39.7 39.7
Soybean meal 19.15 19.15
Rapeseed meal 3.97 3.97
Sugarbeet pulp 10.3 10.3
Ground limestone 1.36 1.36
Monocalciumphosphate 1.20 1.20
Sodium chloride 0.46 0.46
SoftAcid 0.88 0.88
Microminerals, swinec 0.08 0.08
L-lysine 0.27 0.27
DL-methionine 0.16 0.16
L-threonine 0.115 0.115
D-cholinechloride 0.063 0.063
Vitaminpremix swined 0.053 0.053
aDiet with regular butter as fat supplement
bDiet with a special CLA+VA rich butter as fat supplement
cVitamins,: Providing the following amounts per kg of feed: Vitamin A 
9000 IU; Vitamin D3 1100 IU; Vitamin E 110 mg; Vitamin K3 2 mg; 
Thiamin 2 mg; Riboflavin 5 mg; Vitamin B6 3 mg; Vitamin B12 22 ug; 
Pantothenic acid 18 mg; Niacin 22 mg; Biotin 0.2 mg; Folate 1.5 mg.
dMicrominerals: Providing the following amounts per kg of feed: Zn 
112 mg; Fe 80 mg; Mn 60 mg; Cu 16 mg; I 1 mg; Se 0.4 mg.Lipids in Health and Disease 2008, 7:31 http://www.lipidworld.com/content/7/1/31
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Fatty acid analyses
Fatty acid composition in serum, feed concentrate, palm
oil and butter were determined by gas chromatography.
Lipids were extracted according to Folch et al. [26]. For
lipid extraction from serum a modified method was used:
0.2 ml serum was mixed with 0.3 ml 0.5 M KH2 PO4, 1.5
ml chloroform and 0.5 ml methanol. After centrifugation
at 1700 g for 10 minutes, the lower phase was transferred
to new tubes, the solvents were evaporated by N2, and lip-
ids resolved in heptane. Fat from serum and diet were
methylated by the method described by Kramer et al. [27],
using both sodium methoxide and methanolic HCl 3N
(Supelco, PA, USA). Subsequently, the fatty acid methyl
esters were analyzed using a Finnigan Focus gas chroma-
tograph with a 100 m capillary column (CP Sil 88 WCOT,
100-m × 0.25 mm, Chrompack, Middelburg, Nether-
land). Peak areas of fatty acids were used to calculate the
amount of fatty acids (g/100 g fat) by theoretical response
factors [28]. Standard fatty acids of known composition
were run to identify the fatty acids in the samples. Plasma
control samples were extracted, methylated and analysed
by every 10th sample.
Plasma analyses
The heparin-plasma analyses were carried out on a Cobas
Mira autoanalyzer using the following kits: nonesterified
fatty acids (NEFA) (NEFA C ACS-ACOD method. Wako
Chemicals, VA, USA), triacylglycerol (Triglycerides 100,
ABX diagnostics, Montpellier, France), total cholesterol
(Cholesterol 100–250, ABX diagnostics, Montpellier,
France), high density lipoprotein-cholesterol (HDL-cho-
lesterol direct, ABX diagnostics, Montpellier, France) and
glucose (Glucose HK 125 kit, ABX diagnostics, Montpel-
lier, France). Low density lipoptotein-(LDL) cholesterol
was calculated using the Friedewald equation [29]. The
interassay coefficients of variation were the following:
total cholesterol 2%, HDL-cholesterol 5%, triacylglycerols
3%, NEFA 2.5%.
LDL particle size distribution was determined by gradient
gel electrophoresis as described by Sjogren et al. [5].
Briefly, a lipoprotein-rich fraction (containing very low
density lipoprotein (VLDL) to LDL) was isolated from
freshly thawed EDTA-plasma by adjusting the density to
1.070 kg/L and subsequent ultracentrifugation (142500 g
for 22 h, 4°C). Recovery of total plasma apoB was 77 ±
12% (n = 8). The lipoprotein-rich fraction was applied to
a 3–7.5% polyacrylamide gel together with standard lipo-
proteins (isolated human Lp(a) and LDL) and proteins
(thyroglobulin mono- and dimer, Pharmacia, LKB, Stock-
holm, Sweden) of known size and run for 20 h at 80 V.
Gels were stained for protein (0.04% Coomassie Brilliant
Blue, Serva, Heidelberg, Germany) and analyzed using a
Fuji LAS-1000 system and Image Gauge software to give
peak particle size of LDL and relative distribution of LDL
in predefined subfractions with cut-offs: LDL-I (27.0–25.0
nm), LDL-II (25.0–23.5 nm), LDL-III (23.5–22.5 nm)
and LDL-IV (22.5–21.0 nm), corresponding to densities
of 1.006–1.030, 1.030–1.040, 1.040–1.050 and 1.050–
1.063 kg/L, respectively. A density of 1.040 kg/L is a classic
boundary for dividing LDL into large and small particles
[30] rendering LDL subclasses III and IV as small dense
LDL with this method.
Statistical methods
The results of the plasma and serum analyses are pre-
sented as mean values, and standard deviation and p-val-
ues are given. Data were analyzed by using the statistical
package in Microsoft Office Excel, 2003, using TTEST,
two-tailed distribution and two-sample equal variance.
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